The Enterprise Value as of November 2025 (TTM) for Poseida Therapeutics, Inc. (PSTX) is 959.32M

According to Poseida Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 959.32M. This represents a change of 188.70% compared to the average of 332.28M of the last 4 quarters.

Poseida Therapeutics, Inc. (PSTX) Historical Enterprise Value (quarterly & annually)

How has PSTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Poseida Therapeutics, Inc. over the last ten years is 526.86M. The current 959.32M Enterprise Value has changed 18.11% with respect to the historical average. Over the past ten years (40 quarters), PSTX's Enterprise Value was at its highest in in the March 2020 quarter at 879.91M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Poseida Therapeutics, Inc. (PSTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Poseida Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Poseida Therapeutics, Inc. (PSTX) Average Enterprise Value

How has PSTX Enterprise Value performed in the past?

The current Enterprise Value of Poseida Therapeutics, Inc. (PSTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Poseida Therapeutics, Inc. (PSTX) Enterprise Value vs. Peers

How is PSTX’s Enterprise Value compared to its peers?

Poseida Therapeutics, Inc.’s Enterprise Value is less than Gracell Biotechnologies Inc. (5.73B), greater than Harpoon Therapeutics, Inc. (829.47M), greater than Albireo Pharma, Inc. (677.78M), less than Verve Therapeutics, Inc. (966.13M), less than Intercept Pharmaceuticals, Inc. (1.08B), greater than Crescent Biopharma, Inc. (48.94M), greater than Chimerix, Inc. (770.49M), greater than VectivBio Holding AG (848.58M), less than Avid Bioservices, Inc. (971.01M), greater than Icosavax, Inc. (718.99M),

Build a custom stock screener for Poseida Therapeutics, Inc. (PSTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poseida Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poseida Therapeutics, Inc. (PSTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poseida Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.